Drawing for ADENOPURE LS

USPTO serial 76517475

ADENOPURE LS

Reviewed by CopyMark Law Group

Reg. 2928199Status 710
Filing date
Status date
Registration date
Feb 22, 2005
Examiner
FLETCHER, TRACY L
Law office
TMO LAW OFFICE 115

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ADENOPURE LS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberta Jacobs-Meadway

Roberta Jacobs-Meadway ECKERT SEAMANS CHERIN & MELLOTT, LLC50 SOUTH 16TH STREETPHILADELPHIA, PA 19102-2516UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Large scale adenovirus purification kit containing biochemical reagents, buffer solutions, syringe, clarification filter, and a membrane absorber for scientific laboratory use and scientific purposes and biotechnology and biomedical researchSECTION 8 - CANCELLEDOct 27, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2015CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jan 14, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 8, 2011C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 7, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 25, 2011E815TEAS SECTION 8 & 15 RECEIVED—
Apr 18, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 16, 2004REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Nov 22, 2004ALIEASSIGNED TO LIE—
Nov 14, 2004CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 3, 2004SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 14, 2004IUAFUSE AMENDMENT FILED—
Oct 14, 2004MAILPAPER RECEIVED—
Oct 7, 2004EX1GSOU EXTENSION 1 GRANTED—
Sep 30, 2004EXT1SOU EXTENSION 1 FILED—
Sep 30, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 30, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 6, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2003NPUBNOTICE OF PUBLICATION—
Nov 10, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2003CNEAEXAMINER'S AMENDMENT MAILED—
Nov 9, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance